At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Associate Director, Cyber Readiness & Executive Reporting
The Associate Director, Cyber Readiness & Executive Reporting will report to the Head of Cyber Governance within the Cybersecurity department. The Cyber Governance function aims to increase the understanding of Cybersecurity across the enterprise while also creating the standards needed to ensure BMS resilience. The Cyber Governance team is also responsible for operational excellence of the Cybersecurity department. The Associate Director, Cyber Readiness & Executive Reporting will be responsible for:
* Leading cyber education and awareness efforts across the enterprise, including activities such as: developing and executing relevant cyber awareness campaigns, managing the launch and execution of a human security risk pilot, measuring and improving adoption of security behaviors, leading cybersecurity awareness/insight sessions with Business Units
* Overseeing the enterprise Phishing Protection Program, including the overall program orchestration and execution (e.g., selection of simulations, collaboration with third party partners and internal stakeholders, reporting and measurement of program effectiveness), and driving innovation to improve efficiencies where possible
* Formalizing and managing the Cyber Governance Executive Reporting function, including activities such as the development of executive and Board-level briefings, development and management of status dashboards for special projects, supporting other towers within Cybersecurity to drive consistency with executive communications
* Managing Cyber Readiness Exercises, including planning, managing and supporting Business Unit requests for cyber readiness exercises, supporting the Head of Cyber Governance and the Chief Information Security Officer (CISO) in planning for executive level exercises, and managing after-actions, target education efforts, gap closure initiatives and executive debriefs
* Spearheading cross-functional initiatives, such as management and reporting on remediation actions across cybersecurity towers, leading problem management and process improvement initiatives in collaboration with the Cybersecurity leadership team
The candidate will work with third party partners and matrixed teams in executing responsibilities outlined above.
Key Competencies:
7+ years of experience leading large-scale programs and initiatives, preferably in a risk management or related discipline
3+ years of experience in leading matrix teams, managing employees, or overseeing third party vendors
3+ years of experience in leading or supporting business transformation, organizational change and/or behavior efforts
Excellent communication skills, both written and verbal are required
Strong PowerPoint presentation and visualization skills
Executive presence and facilitation skills to drive consensus, support workshops
Attention to detail to support reporting and management of actions
Problem solver mindset Proactive at analysis of an issue/gap and energetic towards solution development
Growth mindset - Proactive at keeping current with advances in cybersecurity
Cybersecurity experience preferred
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.